EKF Diagnostics Holdings plc (AIM:EKF)
London · Delayed Price · Currency is GBP · Price in GBX 25.81
+0.71 (2.83%)
Aug 12, 2026, 8:15 AM GMT
EKF Diagnostics Holdings Market Cap
EKF Diagnostics Holdings has a market cap or net worth of 108.06 million as of August 12, 2026. Its market cap has decreased by -20.06% in one year.
Market Cap
108.06M
Enterprise Value
96.98M
Revenue
51.56M
Ranking
n/a
PE Ratio
53.42
Stock Price
25.81
ChartMarket Cap Chart
Since June 30, 2003, EKF Diagnostics Holdings's market cap has increased from 2.27M to 108.06M, an increase of 4,652.82%. That is a compound annual growth rate of 18.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 108.06M | -5.68% |
| Dec 31, 2025 | 114.57M | -6.48% |
| Dec 31, 2024 | 122.51M | -14.69% |
| Dec 29, 2023 | 143.61M | -36.87% |
| Dec 30, 2022 | 227.47M | -34.63% |
| Dec 31, 2021 | 347.95M | 6.58% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 184.51B |
| GSK plc | 78.56B |
| Haleon | 32.54B |
| Smith & Nephew | 9.36B |
| Diaceutics | 129.55M |
| Scancell Holdings | 114.56M |
| AOTI, Inc. | 103.70M |
| INSPECS Group | 98.62M |